Orange Book product · Generic (ANDA)
METHYLERGONOVINE MALEATE
METHYLERGONOVINE MALEATE
At a glance
May 15, 2018
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 15, 2018
8 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
METHYLERGONOVINE MALEATE
Strength
0.2MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 210424
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of METHYLERGONOVINE MALEATE
- —METHERGINEBrand (NDA)
NDA 006035 · EDISON THERAPS LLC
- 2021METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 211919 · RISING
- 2020METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 212233 · TP ANDA HOLDINGS
- 2019METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 211455 · TEVA PHARMS USA
- 2018METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 211483 · AMNEAL PHARMS
- 2011METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 091577 · CHARTWELL RX
- 2010METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 040889 · BRECKENRIDGE
- 2008METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 090193 · AM REGENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
